finance
Rosen Law Firm Announces Class Action Lawsuit Against Gossamer Bio for Securities Purchases
Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Gossamer Bio, Inc. securities between June 16, 2025, and February 20, 2026. A lawsuit has already been filed, and affected investors may seek compensation through a contingency fee arrangement. The deadline to move as lead plaintiff is June 1, 2026.
Apr 23, 8:59 PM·1m read1 source
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Traded on NASDAQ under the ticker GOSS, covering the period between June 16, 2025, and February 20, 2026, inclusive. The announcement came in New York on April 23, 2026, according to Benzinga. A class action lawsuit has already been filed against Gossamer Bio, Inc.
Purchasers of Gossamer securities during the class period may be entitled to compensation without payment of out-of-pocket fees or costs through a contingency fee arrangement, Benzinga reported. case_id=61894. , toll-free at 866-767-3653.
Com to join the class action. Those wishing to serve as lead plaintiff must move the Court no later than June 1, 2026.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
